Florida Institute of Human and Machine Cognition Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2018
NCT03659825
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Florida Institute for Human & Machine Cognition | Florida Institute of Human and Machine Cognition

Active Ingredients

Drugs in Phase 2 Trials (1)

oxytocin (syntocinon) (1 trial)

Drugs in Other Trials (1)

ketone monoester (1 trial)

Indications

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 2